Said on Wednesday that the government may sell or swap it's doses of the AstraZeneca Cove in 19 vaccine after a clinical trials showed it only offered a minimal protection against mild to moderate infection by the fast spreading 51 y dot V two variant that says the country, the worst hit in Africa by the coronavirus pandemic, prepares to roll out an alternative shot by a U.

S manufacturing next week.

We're not sell the AstraZeneca to other countries.

E did say that.

In fact, I was surprised.

This morning.

I woke up with a couple of emails from some of the countries.

Well, consider it will consider mainly that first, our scientists must tell us what we do with it.

One million doses of the AstraZeneca vaccine, produced by the Serum Institute of India landed in the country last week.

Monkeys said South Africa had contacted the Serum institute.

About 500,000 shots due to arrive in the coming weeks.

On would be discussing a swap with the Kovacs vaccine distribution scheme.

It's not clear how an onward sale us what may work or if AstraZeneca would agree to such a move, Experts are positive the vaccine will still offer protection against severe infection on death from the variant.

Nevertheless, South Africa, where infections are approaching 1.5 million, is now turning to Johnson and Johnson.

It's vaccine was 89% effective at preventing severe disease and 57% against moderate to severe in the South African leg of a global trial in which 95% of infections were due to the 51 wide V two variant.

Given the outcomes off, the African Studies Department of Health will continue as planned.

Phase phase one vaccination targeting the health workers using the Johnson and Johnson vaccine instead of the astronauts.

Any care vaccine Keys said vaccination of health workers in the form of an implementation study would begin sometime next week.